229.02 - 234.51
169.21 - 260.10
55.82M / 54.92M (Avg.)
32.24 | 7.26
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-5.49%
Both yoy net incomes decline, with VUZI at -114.10%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
5.54%
Less D&A growth vs. VUZI's 36.72%, reducing the hit to reported earnings. David Dodd would confirm that core assets remain sufficient.
-661.70%
Negative yoy deferred tax while VUZI stands at 0.00%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
-0.77%
Negative yoy SBC while VUZI is 513.85%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
61.89%
Slight usage while VUZI is negative at -15099.05%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
-954.41%
Both yoy AR lines negative, with VUZI at -3020.76%. Martin Whitman would suspect an overall sector lean approach or softer demand.
-11092.31%
Both reduce yoy inventory, with VUZI at -39.86%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
6588.15%
AP growth well above VUZI's 888.82%. Michael Burry would be concerned about potential late payments or short-term liquidity strain relative to competitor.
-164.58%
Both reduce yoy usage, with VUZI at -45.47%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
352.09%
Lower 'other non-cash' growth vs. VUZI's 8301.10%, indicating steadier reported figures. David Dodd would confirm no missed necessary write-downs or gains.
-4.24%
Both yoy CFO lines are negative, with VUZI at -39.14%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-53.99%
Negative yoy CapEx while VUZI is 83.49%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
-400.00%
Negative yoy acquisition while VUZI stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
20.33%
Purchases growth of 20.33% while VUZI is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
-20.22%
We reduce yoy sales while VUZI is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
No Data
No Data available this quarter, please select a different quarter.
-76.62%
We reduce yoy invests while VUZI stands at 83.49%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
-74.00%
We cut debt repayment yoy while VUZI is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
No Data
No Data available this quarter, please select a different quarter.
13.76%
Buyback growth of 13.76% while VUZI is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.